KATHI NIFFENEGGER Insider Trading
Get free email notifications about insider trading for KATHI NIFFENEGGER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KATHI NIFFENEGGER. KATHI NIFFENEGGER is a Chief Financial Officer in Stellar Biotechnologies, Inc. ($SBOT).
Address: C/O STELLAR BIOTECHNOLOGIES, INC. 332 EAST SCOTT STREET PORT HUENEME 93041 CA
Companies in which KATHI NIFFENEGGER is an Insider
Edesa Biotech, Inc.
Trading Symbol: SBOTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KATHI NIFFENEGGER: Chief Financial Officer
Holdings: 1,827 shares
Current Value: $3,380
Latest Transaction: Apr 26 2021
$SBOT Market Capitalization: $18.04M
$SBOT Previous Close: $1.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of KATHI NIFFENEGGER
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 26 2021 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 5.45 | 80,000 | 436,000 | 80,000 | |
Nov 09 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | X | 4.00 | 609 | 2,436 | 0 | |
Nov 09 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Buy | X | 4.00 | 609 | 2,436 | 1,827 | 1.2 K to 1.8 K (+50.00 %) |
Oct 14 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 7.44 | 50,000 | 372,000 | 50,000 | |
Feb 14 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 3.16 | 88,699 | 280,289 | 88,699 | |
Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 4.00 | 609 | 2,436 | 609 | |
Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 4.80 | 914 | 4,387 | 914 |